Li YR, Ding DC. Hemorrhagic Bartholin’s cyst in a woman using anti-platelet medication: A case report and review of the literature. World J Clin Cases 2023; 11(24): 5755-5761 [PMID: 37727722 DOI: 10.12998/wjcc.v11.i24.5755]
Corresponding Author of This Article
Dah-Ching Ding, MD, PhD, Professor, Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, No. 707 Chung-Yang Road, Sec 3, Hualien 970, Taiwan. dah1003@yahoo.com.tw
Research Domain of This Article
Obstetrics & Gynecology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Aug 26, 2023; 11(24): 5755-5761 Published online Aug 26, 2023. doi: 10.12998/wjcc.v11.i24.5755
Hemorrhagic Bartholin’s cyst in a woman using anti-platelet medication: A case report and review of the literature
Yi-Rong Li, Dah-Ching Ding
Yi-Rong Li, Dah-Ching Ding, Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien 970, Taiwan
Author contributions: Li YR contributed to the methodology, formal analysis, data curation, writing and original draft preparation of this manuscript; Ding DC contributed to the conceptualization and writing, review and editing of this paper; and all authors have read and agreed to the published version of the manuscript.
Informed consent statement: Written informed consent was obtained from the patient(s) to publish this paper.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dah-Ching Ding, MD, PhD, Professor, Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, No. 707 Chung-Yang Road, Sec 3, Hualien 970, Taiwan. dah1003@yahoo.com.tw
Received: May 3, 2023 Peer-review started: May 3, 2023 First decision: June 21, 2023 Revised: June 30, 2023 Accepted: August 3, 2023 Article in press: August 3, 2023 Published online: August 26, 2023 Processing time: 114 Days and 7.5 Hours
Abstract
BACKGROUND
We report the case of a postmenopausal female with a hemorrhagic Bartholin’s cyst who has been using an antiplatelet medication.
CASE SUMMARY
A postmenopausal woman, 84 years of age, had a medical history of hypertension, diabetes mellitus, coronary artery disease (three-vessel disease), chronic kidney disease (stage 3), and dementia. The patient has been taking clopidogrel, an antiplatelet medication, for several years. She presented at our outpatient clinic complaining of painful swelling over her left vulva for several days. A Bartholin’s cyst over the left vulva was suspected, and the patient underwent marsupialization under local anesthesia, which was well-tolerated. During the incision procedure, bright-red blood with some blood clots was discharged, and a hemorrhagic Bartholin’s cyst was observed. There was no recurrence of the hemorrhagic Bartholin’s cyst during the 6-mo subsequent follow-up period.
CONCLUSION
Hemorrhagic Bartholin’s cysts rarely occur. We report the case of a postmenopausal female with a hemorrhagic Bartholin’s cyst who had been on antiplatelets and was successfully treated with marsupialization. No recurrence was noted during the 6-mo follow-up period. Older females taking antiplatelets should be cautious of bleeding when presenting with a Bartholin’s cyst.
Core Tip: We report a case with a hemorrhagic Bartholin’s cyst. We updated the information on Bartholin’s cyst regarding symptoms, signs, diagnosis, and treatment. Because of the rarity of a hemorrhagic Bartholin’s cyst, we provided a strategy to diagnose and treat this kind of Bartholin’s cyst.
